Ilisten M Jones, MD
Allergy/Immunology · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 4 carriers
- Offices
- 2
Offices
2 locations · Allergy and Asthma Medical Group of the Bay Area Inc · Csi Medical Group
Looking this up.
Plans that list them
24 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jones’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A125510 · Current
Licensed to practise in California · since 2013 · expires 2026-12-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$46,745
Medicare paid this office $46,745 for 52 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Test for allergy using allergenic extract | 21 | $2,618 | $3 |
| New patient visit (45+ min) | 14 | $2,070 | $148 |
| Return visit (30+ min) | 12 | $1,374 | $92 |
| Test for allergy using allergenic extract injected into skin | 17 | $628 | $8 |
| Test to measure expiratory airflow and volume | 11 | $340 | $26 |
See all 7 services
| Test for allergy using allergenic extract | 21 | $2,618 | $3 |
| New patient visit (45+ min) | 14 | $2,070 | $148 |
| Return visit (30+ min) | 12 | $1,374 | $92 |
| Test for allergy using allergenic extract injected into skin | 17 | $628 | $8 |
| Test to measure expiratory airflow and volume | 11 | $340 | $26 |
| Test to measure the level of nitric oxide gas | 14 | $331 | $19 |
| Administration and interpretation of patient-focused health risk assessment | 23 | $89 | $3 |
Who their Medicare patients are
52 Original Medicare patients in 2024. Average age 71 · Women 62% · Health risk score 0.68. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 1.
Conditions among them: High blood pressure 58%.
The office billed $110,831, Medicare allowed $60,749 and paid $46,745; for 1,915 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 52 | 1,915 | 71 | 0.68 | $110,831 | $46,745 |
| 2023 | 61 | 4,516 | 70 | 1.07 | $225,369 | $91,245 |
| 2022 | 44 | 3,093 | 68 | 1.05 | $197,854 | $93,999 |
| 2021 | 68 | 3,409 | 72 | 0.99 | $215,864 | $105,759 |
| 2020 | 58 | 2,655 | 69 | 1.03 | $183,101 | $88,600 |
| 2019 | 64 | 7,513 | 70 | 0.98 | $238,048 | $100,032 |
| 2018 | 59 | 9,908 | 70 | 0.80 | $275,883 | $126,130 |
| 2017 | 22 | 509 | 68 | 0.93 | $20,331 | $7,036 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Test for allergy using allergenic extract | 23 | $3,756 | $4 |
| New patient visit (45+ min) | 23 | $3,279 | $143 |
| Return visit (30+ min) | 14 | $1,818 | $91 |
| Professional service for multiple injections of allergen | 11 | $1,449 | $12 |
| Short return visit (20+ min) | 11 | $834 | $64 |
| Test for allergy using allergenic extract injected into skin | 15 | $672 | $9 |
| Administration and interpretation of patient-focused health risk assessment | 24 | $152 | $3 |
2022: 2 services
| Long return visit (40+ min) | 11 | $2,401 | $141 |
| Short return visit (20+ min) | 16 | $1,082 | $57 |
2021: 7 services
| Short return visit (20+ min) | 23 | $3,079 | $81 |
| Return visit (30+ min) | 15 | $2,524 | $120 |
| New patient visit (45+ min) | 13 | $2,051 | $158 |
| Test for allergy using allergenic extract | 13 | $1,919 | $4 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose | 17 | $590 | $35 |
| Test for allergy using allergenic extract injected into skin | 11 | $469 | $9 |
| Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use | 20 | $0 | $0 |
2020: 6 services
| Return visit (30+ min) | 21 | $2,911 | $88 |
| Test for allergy using allergenic extract | 12 | $1,810 | $4 |
| New patient visit (45+ min) | 11 | $1,478 | $134 |
| Short return visit (20+ min) | 19 | $1,381 | $63 |
| Test to measure expiratory airflow and volume | 17 | $436 | $26 |
| Test to measure the level of nitric oxide gas | 14 | $235 | $17 |
2019: 7 services
| New patient visit (45+ min) | 27 | $4,148 | $154 |
| Test for allergy using allergenic extract | 25 | $4,062 | $4 |
| Return visit (30+ min) | 26 | $2,993 | $91 |
| Short return visit (20+ min) | 22 | $1,695 | $65 |
| Test to measure expiratory airflow and volume | 30 | $1,523 | $35 |
| Test for allergy using allergenic extract injected into skin | 22 | $1,190 | $8 |
| Test to measure the level of nitric oxide gas | 26 | $743 | $21 |
2018: 6 services
| Return visit (30+ min) | 29 | $5,157 | $92 |
| New patient visit (45+ min) | 33 | $4,844 | $147 |
| Test for allergy using allergenic extract | 24 | $4,569 | $5 |
| Test to measure expiratory airflow and volume | 27 | $1,603 | $35 |
| Test for allergy using allergenic extract injected into skin | 21 | $1,242 | $8 |
| Test to measure the level of nitric oxide gas | 26 | $850 | $21 |
2017: 1 service
| New patient visit (45+ min) | 12 | $1,630 | $136 |
Medicaid work
$216 in 2020
Medicaid paid $216 for 25 billed services this clinician did in 2020, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 25 | $216 |
| 2020 | 25 | 1 | 13 | $216 |
| 2019 | 79 | 1 | 12 | $688 |
| 2018 | 237 | 1 | 16 | $2,074 |
See the largest Medicaid services in earlier years
2019
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 79 | $688 |
2018
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 237 | $2,074 |
Drugs they prescribed that Part D paid
$75,853
Pharmacies billed $75,853 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 251) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.
168 generic and 83 brand-name prescriptions · $75,853 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 12 | $41,211 | $3,434 |
| Breo Ellipta | 21 | $9,905 | $472 |
| Epinephrine | 18 | $3,208 | $178 |
| Azelastine | 40 | $1,444 | $36 |
| Fluticasone Propionate | 20 | $450 | $22 |
See all 8 drugs
| Dupixent | 12 | $41,211 | $3,434 |
| Breo Ellipta | 21 | $9,905 | $472 |
| Epinephrine | 18 | $3,208 | $178 |
| Azelastine | 40 | $1,444 | $36 |
| Fluticasone Propionate | 20 | $450 | $22 |
| Levocetirizine Dihydrochloride | 43 | $426 | $10 |
| Montelukast | 29 | $216 | $7 |
| Famotidine | 13 | $25 | $2 |
Year by year
| 2024 | 251 | 58 | 0% (0) | 33% | $75,853 |
| 2023 | 276 | 54 | 0% (0) | 32% | $92,013 |
| 2022 | 278 | 45 | 0% (0) | 36% | $199,342 |
| 2021 | 319 | 46 | 0% (0) | 36% | $242,065 |
| 2020 | 351 | 51 | 0% (0) | 30% | $147,212 |
| 2019 | 283 | 55 | 0% (0) | 44% | $64,206 |
| 2018 | 236 | 59 | 0% (0) | 31% | $30,205 |
| 2017 | 163 | 43 | 0% (0) | 29% | $14,218 |
| 2016 | 41 | 20 | 0% (0) | 46% | $3,411 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Breo Ellipta | 15 | $10,120 | $675 |
| Epinephrine | 13 | $2,342 | $180 |
| Azelastine | 41 | $1,508 | $37 |
| Levocetirizine Dihydrochloride | 44 | $731 | $17 |
| Mometasone Furoate | 14 | $721 | $52 |
| Montelukast | 38 | $683 | $18 |
| Fluticasone Propionate | 24 | $377 | $16 |
| Famotidine | 13 | $333 | $26 |
2022: 7 drugs
| Breo Ellipta | 20 | $11,677 | $584 |
| Flovent Hfa | 14 | $5,220 | $373 |
| Epinephrine | 11 | $2,494 | $227 |
| Azelastine | 37 | $2,236 | $60 |
| Montelukast | 39 | $1,047 | $27 |
| Levocetirizine Dihydrochloride | 42 | $493 | $12 |
| Fluticasone Propionate | 19 | $209 | $11 |
2021: 7 drugs
| Cuvitru | Immune globulin | 13 | $161,586 | $12,430 |
| Breo Ellipta | None | 32 | $16,925 | $529 |
| Flovent Hfa | None | 19 | $8,412 | $443 |
| Azelastine | None | 54 | $3,130 | $58 |
| Montelukast | None | 67 | $935 | $14 |
| Levocetirizine Dihydrochloride | None | 38 | $534 | $14 |
| Fluticasone Propionate | None | 20 | $253 | $13 |
2020: 8 drugs
| Dupixent | 14 | $46,492 | $3,321 |
| Breo Ellipta | 30 | $12,372 | $412 |
| Trelegy Ellipta | 11 | $11,591 | $1,054 |
| Flovent Hfa | 12 | $4,367 | $364 |
| Azelastine-Fluticasone | 14 | $2,612 | $187 |
| Azelastine | 50 | $2,089 | $42 |
| Montelukast | 81 | $1,374 | $17 |
| Levocetirizine Dihydrochloride | 41 | $431 | $11 |
2019: 8 drugs
| Breo Ellipta | 37 | $15,122 | $409 |
| Trelegy Ellipta | 11 | $8,112 | $737 |
| Symbicort | 11 | $5,881 | $535 |
| Flovent Hfa | 12 | $4,028 | $336 |
| Dymista | 15 | $2,867 | $191 |
| Azelastine | 44 | $1,820 | $41 |
| Montelukast | 72 | $1,422 | $20 |
| Levocetirizine Dihydrochloride | 15 | $194 | $13 |
2018: 6 drugs
| Breo Ellipta | 16 | $8,131 | $508 |
| Epinephrine | 11 | $4,306 | $391 |
| Montelukast | 70 | $1,250 | $18 |
| Azelastine | 19 | $1,162 | $61 |
| Levocetirizine Dihydrochloride | 20 | $193 | $10 |
| Hydroxyzine | 11 | $179 | $16 |
2017: 4 drugs
| Montelukast | 55 | $847 | $15 |
| Azelastine | 14 | $620 | $44 |
| Fluticasone Propionate | 12 | $151 | $13 |
| Hydroxyzine | 14 | $136 | $10 |
Money from drug and device companies
$61 in 2025
| 2025 | 1 | 4 | None | $61 |
| 2024 | 1 | 1 | None | $15 |
| 2020 | 10 | 15 | None | $297 |
| 2019 | 16 | 101 | None | $1,913 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Cibinqo | $61 | 4 payments
|
See all 4 published payments
| Pfizer | Education · 2025-05-16 | Cibinqo | $15 |
| Pfizer | Education · 2025-04-23 | Cibinqo | $15 |
| Pfizer | Education · 2025-02-27 | Cibinqo | $15 |
| Pfizer | Education · 2025-02-03 | Cibinqo | $15 |
See earlier years (2024, 2020, 2019)
2024: $15
| Pfizer | Cibinqo | $15 | 1 payment
|
2020: $297
| GlaxoSmithKline | Trelegy Ellipta | $48 | 3 payments
|
| ALK-Abello | Odactra | $47 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $43 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $41 | 2 payments
|
| Genzyme | Dupixent | $27 | 1 payment
|
| OptiNose US | Xhance | $22 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $20 | 1 payment
|
| Pfizer | Cutaquig | $19 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $18 | 1 payment
|
| Aimmune Therapeutics | Palforzia | $14 | 1 payment
|
2019: $1,913
| Teva Pharmaceuticals USA | Cinqair | $316 | 9 payments
|
| Regeneron Healthcare Solutions | Dupixent | $266 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $181 | 8 payments
|
| ALK-Abello | Odactra | $147 | 10 payments
|
| Kaleo | Auvi-Q | $146 | 9 payments
|
| Novartis Pharmaceuticals | Xolair | $139 | 8 payments
|
| GlaxoSmithKline | Nucala | $138 | 12 payments
|
| Shire North American Group | Takhzyro | $128 | 7 payments
|
| OptiNose US | Xhance | $127 | 7 payments
|
| Genzyme | Dupixent | $83 | 3 payments
|
| Pfizer | Eucrisa | $57 | 3 payments
|
| Greer Laboratories | Oralair | $56 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $53 | 3 payments
|
| Circassia Pharmaceuticals | Tudorza Pressair | $33 | 2 payments
|
| Covis Pharma B.V. | Alvesco | $29 | 2 payments
|
| Sunovion Pharmaceuticals | Lonhala Magnair | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 69.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1407148943
- Licence
- CA A125510California A125510: Current · expires 2026-12-31
- Trained
- Harvard Medical School, 2011
- Group
- Allergy and Asthma Medical Group of the Bay Area Inc · Csi Medical Group
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207K00000X (207K00000X)
- Mailing address
- 370 N Wiget Ln, Suite 210, Walnut Creek, CA, 94598
- NPI first listed
- 2011-05-03
- NPI last updated
- 2016-07-25
This is when the NPI record was last certified, not a medical board exam.